These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086. Nyangale EP; Farmer S; Keller D; Chernoff D; Gibson GR Anaerobe; 2014 Dec; 30():75-81. PubMed ID: 25219857 [TBL] [Abstract][Full Text] [Related]
23. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Reeves AE; Theriot CM; Bergin IL; Huffnagle GB; Schloss PD; Young VB Gut Microbes; 2011; 2(3):145-58. PubMed ID: 21804357 [TBL] [Abstract][Full Text] [Related]
24. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Fekety R; Silva J; Kauffman C; Buggy B; Deery HG Am J Med; 1989 Jan; 86(1):15-9. PubMed ID: 2910090 [TBL] [Abstract][Full Text] [Related]
25. Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment. Lv Z; Peng G; Liu W; Xu H; Su J Antimicrob Agents Chemother; 2015 Jul; 59(7):3726-35. PubMed ID: 25824219 [TBL] [Abstract][Full Text] [Related]
26. [Studies on Clostridium difficile and antimicrobial associated diarrhea or colitis]. Kobayashi T Jpn J Antibiot; 1983 Feb; 36(2):464-76. PubMed ID: 6854944 [TBL] [Abstract][Full Text] [Related]
27. Spores of Bacillus coagulans GBI-30, 6086 show high germination, survival and enzyme activity in a dynamic, computer-controlled in vitro model of the gastrointestinal tract. Keller D; Verbruggen S; Cash H; Farmer S; Venema K Benef Microbes; 2019 Feb; 10(1):77-87. PubMed ID: 30694101 [TBL] [Abstract][Full Text] [Related]
28. The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Džunková M; D'Auria G; Xu H; Huang J; Duan Y; Moya A; Kelly CP; Chen X Front Cell Infect Microbiol; 2016; 6():119. PubMed ID: 27757389 [TBL] [Abstract][Full Text] [Related]
29. Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection. van Opstal E; Kolling GL; Moore JH; Coquery CM; Wade NS; Loo WM; Bolick DT; Shin JH; Erickson LD; Warren CA J Infect Dis; 2016 Jul; 214(1):130-9. PubMed ID: 26917573 [TBL] [Abstract][Full Text] [Related]
30. Critical role of MAVS in the protection against Clostridium difficile-induced colitis. Zhang P; Mao R; Lv Z; Wang B; Su J Microb Pathog; 2018 Dec; 125():306-312. PubMed ID: 30267893 [TBL] [Abstract][Full Text] [Related]
31. Fidaxomicin vs Vancomycin for the Treatment of a First Episode of Clostridium Difficile Infection: A Meta-analysis and Systematic Review. Al Momani LA; Abughanimeh O; Boonpheng B; Gabriel JG; Young M Cureus; 2018 Jun; 10(6):e2778. PubMed ID: 30112254 [TBL] [Abstract][Full Text] [Related]
32. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites. Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463 [TBL] [Abstract][Full Text] [Related]